Trial Profile
Clinical trial of IV folic acid for diagnostic use in patients with ovarian cancer
Status:
Suspended
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 23 May 2014
Price :
$35
*
At a glance
- Drugs Folic acid (Primary)
- Indications Ovarian cancer
- Focus Diagnostic use
- 23 May 2014 New trial record
- 19 May 2014 CMA applications from the EMA have been withdrawn for vintafolide and companion imaging components technetium-Tc99m etarfolatide and intravenous folic acid based on further review of interim data from the PROCEED trial, according to Merck and Endocyte.